Test Description

What are Platelets?

Platelets (thrombocytes) are small, disc-shaped cell fragments derived from megakaryocytes in the bone marrow. They are essential for hemostasis (stopping bleeding) by forming platelet plugs at sites of vascular injury and providing a surface for blood clotting.

Platelet Function and Lifespan

Lifespan: 7-10 days in circulation
Production: Produced from megakaryocytes in bone marrow; regulated by thrombopoietin (TPO)
Primary hemostasis: Platelets adhere to damaged vessel walls, activate, and aggregate to form platelet plug
Secondary hemostasis: Provide phospholipid surface for coagulation cascade (fibrin clot formation)
Destruction: Removed by spleen and liver after 7-10 days or after activation

How Platelets Work in Hemostasis

When blood vessels are injured, platelets respond through a series of steps:

Adhesion: Platelets stick to exposed collagen via von Willebrand factor (vWF)
Activation: Activated platelets change shape, release granule contents (ADP, serotonin, thromboxane A2)
Aggregation: Released factors recruit more platelets, forming platelet plug
Clot stabilization: Fibrin mesh reinforces platelet plug to form stable clot

Why is Platelet Count Important?

Platelet count provides critical information for clinical decision-making:

Bleeding risk assessment: Low platelets increase bleeding risk, especially with procedures or trauma
Transfusion guidance: Determines need for platelet transfusion before surgery or in bleeding patients
Medication monitoring: Many medications cause thrombocytopenia (heparin, chemotherapy, antibiotics)
Clotting disorder screening: Detects ITP, TTP, HUS, DIC, and hematologic malignancies

Platelet Count vs. Platelet Function: Normal platelet count doesn't guarantee normal hemostasis. Some patients with normal counts have defective platelet function (e.g., aspirin use, von Willebrand disease, uremia). Conversely, patients with mild thrombocytopenia (50,000-100,000/μL) rarely bleed spontaneously if platelets function normally.

Quick Reference

Normal Range: 150,000-450,000/μL (or 150-450 × 10⁹/L)
Critical Low: <10,000/μL (spontaneous bleeding risk)
Critical High: >1,000,000/μL (thrombosis and paradoxical bleeding risk)
Thrombocytopenia: <150,000/μL (low platelets)
Thrombocytosis: >450,000/μL (high platelets)
Primary Use: Assess bleeding risk, guide platelet transfusion, diagnose hematologic disorders
Sample Type: Whole blood (EDTA tube - purple top)
Key Point: Bleeding risk correlates with platelet count; spontaneous bleeding rare above 10,000-20,000/μL

Normal Ranges

Platelet counts are relatively consistent across age and sex, though pregnant women and newborns may have slightly different ranges.

Swipe to see more

Population	Normal Range (/μL)	SI Units (× 10⁹/L)
Adults (male and female)	150,000-450,000	150-450
Pregnant Women	100,000-400,000	100-400
Newborns (0-2 weeks)	150,000-450,000	150-450
Infants and Children	150,000-450,000	150-450

Important Considerations:

Critical values: Platelets <10,000 or >1,000,000 should be reported immediately
Gestational thrombocytopenia: 5-10% of pregnant women develop mild thrombocytopenia (100,000-150,000) in third trimester; usually benign
Pseudothrombocytopenia: Falsely low platelet count due to EDTA-induced platelet clumping (1-2% of samples)
Platelet clumping: Always check peripheral smear if unexplained thrombocytopenia
Ethnic variations: Some populations have slightly lower baseline counts without pathology

Clinical Significance

Thrombocytopenia (Low Platelet Count <150,000/μL)

Thrombocytopenia is classified by mechanism: decreased production, increased destruction, or sequestration.

Decreased Platelet Production

Bone marrow failure: Aplastic anemia, myelodysplastic syndrome
Marrow infiltration: Leukemia, lymphoma, metastatic cancer, myelofibrosis
Nutritional deficiencies: Vitamin B12, folate deficiency (megaloblastic anemia affecting all cell lines)
Medications: Chemotherapy agents, alcohol (direct marrow toxicity)
Viral infections: HIV, hepatitis C, EBV (marrow suppression)

Increased Platelet Destruction

Immune Thrombocytopenia (ITP): Autoantibodies destroy platelets; most common cause in otherwise healthy patients
Drug-induced: Heparin (HIT), quinine, sulfonamides, vancomycin, valproic acid, linezolid
Thrombotic Thrombocytopenic Purpura (TTP): Microangiopathic hemolytic anemia with schistocytes, fever, renal failure, neurologic changes
Hemolytic Uremic Syndrome (HUS): Similar to TTP; often follows E. coli O157:H7 diarrhea in children
Disseminated Intravascular Coagulation (DIC): Consumption of platelets and clotting factors; prolonged PT/PTT, low fibrinogen, elevated D-dimer
Post-transfusion purpura: Rare; severe thrombocytopenia 5-10 days after transfusion

Platelet Sequestration

Hypersplenism: Enlarged spleen sequesters up to 90% of platelets (cirrhosis, portal hypertension, lymphoma)
Splenic sequestration crisis: Acute in sickle cell disease

Dilutional Thrombocytopenia

Massive transfusion: Transfusion of >10 units packed RBCs without platelet replacement
Massive fluid resuscitation: Dilutes circulating platelets

Pregnancy-Related

Gestational thrombocytopenia: Benign; platelets 100,000-150,000 in third trimester
HELLP syndrome: Hemolysis, Elevated Liver enzymes, Low Platelets; severe preeclampsia complication
Preeclampsia/eclampsia: Platelet activation and consumption

Thrombocytosis (High Platelet Count >450,000/μL)

Elevated platelet count is classified as primary (clonal) or secondary (reactive).

Primary (Clonal) Thrombocytosis

Essential thrombocythemia: Myeloproliferative neoplasm with JAK2, CALR, or MPL mutations; platelets often >600,000-1,000,000
Polycythemia vera: Myeloproliferative disorder with elevated RBCs, WBCs, and platelets
Chronic myeloid leukemia (CML): BCR-ABL positive; marked leukocytosis with thrombocytosis
Myelodysplastic syndromes: Especially 5q deletion syndrome

Secondary (Reactive) Thrombocytosis

Acute inflammation or infection: Pneumonia, UTI, inflammatory bowel disease
Chronic inflammatory conditions: Rheumatoid arthritis, Crohn's disease, ulcerative colitis
Tissue damage: Recent surgery, trauma, burns
Iron deficiency: Thrombocytosis common even before anemia develops
Malignancy: Lung, gastric, ovarian, breast cancer (paraneoplastic)
Post-splenectomy: Loss of splenic sequestration; can reach 600,000-1,000,000
Rebound thrombocytosis: After chemotherapy or severe infection recovery
Medications: All-trans retinoic acid (ATRA), G-CSF

Distinguishing Primary vs. Secondary Thrombocytosis: Primary (clonal) thrombocytosis is persistent, often >600,000, associated with other cytopenias or cytoses, and carries thrombosis risk. Secondary (reactive) thrombocytosis is usually <600,000, transient, improves when underlying condition treated, and rarely causes thrombosis. If platelets >600,000 or persistent elevation, refer to hematology.

Interpretation Guidelines

Bleeding Risk by Platelet Count

Swipe to see more

Platelet Count (/μL)	Bleeding Risk	Clinical Implications
>100,000	Minimal	Safe for most procedures; no spontaneous bleeding
50,000-100,000	Mild	Increased surgical bleeding; generally safe for minor procedures
20,000-50,000	Moderate	Increased bleeding with trauma; bruising common; avoid major surgery
10,000-20,000	High	Spontaneous mucosal bleeding (epistaxis, gingival bleeding); consider transfusion
<10,000	Severe	High risk spontaneous bleeding including intracranial hemorrhage; transfuse

Platelet Transfusion Guidelines

Platelet Transfusion Thresholds:

Active bleeding: Transfuse if platelets <50,000/μL (some say <30,000 for minor bleeding)
Major surgery or invasive procedures: Target platelets >50,000/μL pre-procedure
Neurosurgery or ophthalmic surgery: Target platelets >100,000/μL
Prophylactic (no bleeding): Transfuse if <10,000/μL to prevent spontaneous bleeding
Minor procedures (LP, central line): Target >20,000-50,000/μL

DON'T transfuse platelets in:

TTP/HUS: Platelet transfusion can worsen microvascular thrombosis
HIT (Heparin-Induced Thrombocytopenia): Risk of thrombosis, not bleeding
ITP: Transfused platelets are rapidly destroyed; reserve for life-threatening bleeding

Expected Response to Platelet Transfusion

One unit platelets (apheresis): Raises platelet count by ~30,000-50,000/μL in average adult
One unit platelets (pooled): Raises count by ~5,000-10,000/μL per unit (typically 4-6 units pooled)
Post-transfusion check: Measure platelet count 10-60 minutes and 24 hours post-transfusion
Poor response: Suggests platelet refractoriness (alloimmunization, HLA antibodies, splenomegaly, DIC, sepsis)

Approach to Thrombocytopenia

Step 1: Confirm thrombocytopenia - rule out pseudothrombocytopenia by checking peripheral smear

Step 2: Assess bleeding risk and clinical urgency

Step 3: Review medication list for culprit drugs

Step 4: Categorize by mechanism:

Isolated thrombocytopenia (normal WBC/Hgb): ITP, drug-induced, infection
Pancytopenia (low WBC, RBC, platelets): Bone marrow failure, megaloblastic anemia, hypersplenism
Microangiopathic hemolytic anemia (schistocytes on smear): TTP, HUS, DIC, HELLP

Step 5: Order targeted testing:

PT/PTT, fibrinogen, D-dimer (if DIC suspected)
Peripheral smear (schistocytes, platelet clumping)
HIV, HCV (if risk factors present)
Consider bone marrow biopsy if unexplained or concern for malignancy

Interfering Factors

Factors That Decrease Platelets

Medications (most common cause): Heparin (HIT), chemotherapy, valproic acid, antibiotics (vancomycin, linezolid, sulfonamides), anticonvulsants, quinine
Alcohol: Direct bone marrow toxicity and splenic sequestration
Viral infections: HIV, hepatitis C, EBV, CMV, dengue
Hypothermia: Platelet sequestration and dysfunction

Factors That Increase Platelets

Iron deficiency: Even without anemia, iron deficiency commonly causes thrombocytosis
Inflammation: Acute infection, trauma, surgery, inflammatory diseases
Medications: All-trans retinoic acid (ATRA), G-CSF/GM-CSF, epinephrine
Exercise: Strenuous exercise transiently increases platelet count
Smoking: Chronic smokers have mildly elevated platelet counts

Pseudothrombocytopenia

EDTA-induced clumping: Platelets clump in EDTA tubes, causing falsely low automated count (1-2% of samples)
Diagnosis: Review peripheral smear showing platelet clumps; normal platelet count on smear estimation
Solution: Redraw in citrate tube or heparin tube; perform manual platelet count
Clinical significance: No clinical consequence; platelets function normally

Pre-analytical Errors

Clotted sample: Platelets consumed in clot; falsely low count
Delayed processing: Platelets degrade over time; process within 4 hours
Giant platelets: May be counted as small RBCs or WBCs by automated analyzers
Hemolysis: Can interfere with optical platelet counting

Clinical Pearls

"Spontaneous bleeding rare above 10,000-20,000/μL": Patients with platelet counts above this threshold rarely bleed spontaneously unless they have concurrent platelet dysfunction (uremia, aspirin, NSAIDs) or coagulopathy. Focus prophylactic transfusions on those <10,000/μL.

Always check peripheral smear for unexplained thrombocytopenia: Pseudothrombocytopenia (EDTA-induced clumping) occurs in 1-2% of samples. The smear will show platelet clumps and normal platelet numbers. Don't panic and transfuse based on automated count alone.

HIT (Heparin-Induced Thrombocytopenia) causes thrombosis, not bleeding: Despite low platelet count (typically 50,000-150,000), HIT causes dangerous arterial and venous thrombosis. If platelets drop >50% after starting heparin (days 5-14), stop heparin immediately, check HIT antibody, and start alternative anticoagulant (argatroban, bivalirudin). Never transfuse platelets in HIT.

Don't transfuse platelets in TTP/HUS: Thrombotic microangiopathies (TTP, HUS) involve platelet-rich microvascular thrombi. Platelet transfusion worsens microvascular thrombosis and can precipitate stroke or MI. Treatment is plasmapheresis (TTP) or supportive care (HUS), not platelets. Reserve platelet transfusion for life-threatening bleeding only.

ITP diagnosis is exclusion: Immune Thrombocytopenia (ITP) causes isolated thrombocytopenia with normal WBC, hemoglobin, and peripheral smear (except low platelets). Rule out drugs, HIV, HCV, and other causes first. Treatment: corticosteroids, IVIG, or anti-D for platelets <30,000 or bleeding.

Gestational thrombocytopenia is common and benign: 5-10% of pregnant women develop platelet counts 100,000-150,000 in third trimester. This is physiologic, not pathologic. Differentiate from HELLP, preeclampsia (hypertension, proteinuria, elevated LFTs), or ITP (platelets usually <100,000).

Iron deficiency causes thrombocytosis: Even without anemia, iron deficiency commonly elevates platelets to 500,000-700,000. This is reactive thrombocytosis and rarely causes thrombosis. Treat the iron deficiency and platelets will normalize.

Essential thrombocythemia threshold is >450,000: But most patients have counts >600,000-1,000,000. If persistent platelets >600,000 without obvious reactive cause (infection, inflammation, iron deficiency), refer to hematology for JAK2/CALR/MPL mutation testing. ET carries thrombosis risk; may need aspirin or cytoreductive therapy (hydroxyurea).

Post-splenectomy thrombocytosis peaks at 7-21 days: After splenectomy, platelet count rises (loss of splenic sequestration) and can reach 600,000-1,000,000. Usually benign and self-limited. Consider aspirin prophylaxis if >1,000,000 or thrombosis risk factors. Counts typically normalize over weeks to months.

References

Kratz, A., Ferraro, M., Sluss, P. M., & Lewandrowski, K. B. (2004). Laboratory reference values. New England Journal of Medicine, 351, 1548-1564.
Lee, M. (Ed.). (2009). Basic skills in interpreting laboratory data. Ashp.
Farinde, A. (2021). Lab values, normal adult: Laboratory reference ranges in healthy adults. Medscape. https://emedicine.medscape.com/article/2172316-overview?form=fpf
Nickson, C. (n.d.). Critical Care Compendium. Life in the Fast Lane • LITFL. https://litfl.com/ccc-critical-care-compendium/
Farkas, Josh MD. (2015). Table of Contents - EMCrit Project. EMCrit Project. https://emcrit.org/ibcc/toc/

Back to CBC Panel All Lab Values

Medical Disclaimer

For Educational Purposes Only: This content is intended for educational reference and should not be used for clinical decision-making.
Not a Substitute for Professional Judgment: Always consult your local protocols, institutional guidelines, and supervising physicians.
Verify Before Acting: Users are responsible for verifying information through authoritative sources before any clinical application.

AI Assistance Notice

The clinical content and references are curated and reviewed by myself; however, AI was used to assist in organizing, paraphrasing, and formatting the information presented.